KMT2E-AS1 and neoplasm: Previous studies have shown that LINC01004 activates SIGLEC9 (a sialic acid-binding receptor) in tumor-associated macrophages (TAMs) in esophageal squamous cell carcinoma (ESCC), inducing radioresistance and immunosuppression [41].